These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25400822)

  • 1. Dysregulation of JAM-A plays an important role in human tumor progression.
    Zhao C; Lu F; Chen H; Zhao X; Sun J; Chen H
    Int J Clin Exp Pathol; 2014; 7(10):7242-8. PubMed ID: 25400822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of JAM-B in cancer and cancer metastasis (Review).
    Zhao H; Yu H; Martin TA; Teng X; Jiang WG
    Oncol Rep; 2016 Jul; 36(1):3-9. PubMed ID: 27121546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.
    Czubak-Prowizor K; Babinska A; Swiatkowska M
    Mol Cell Biochem; 2022 Jan; 477(1):79-98. PubMed ID: 34533648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of outside-in signaling at the tight junction by junctional adhesion molecule A.
    Severson EA; Parkos CA
    Ann N Y Acad Sci; 2009 May; 1165():10-8. PubMed ID: 19538282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
    Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
    Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?
    Kamola P; Babinska A; Przygodzki T
    Platelets; 2023 Dec; 34(1):2214618. PubMed ID: 37246517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human junction adhesion molecule regulates tight junction resealing in epithelia.
    Liu Y; Nusrat A; Schnell FJ; Reaves TA; Walsh S; Pochet M; Parkos CA
    J Cell Sci; 2000 Jul; 113 ( Pt 13)():2363-74. PubMed ID: 10852816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Junctional adhesion molecule A promotes epithelial tight junction assembly to augment lung barrier function.
    Mitchell LA; Ward C; Kwon M; Mitchell PO; Quintero DA; Nusrat A; Parkos CA; Koval M
    Am J Pathol; 2015 Feb; 185(2):372-86. PubMed ID: 25438062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
    Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
    J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity.
    Ebnet K; Aurrand-Lions M; Kuhn A; Kiefer F; Butz S; Zander K; Meyer zu Brickwedde MK; Suzuki A; Imhof BA; Vestweber D
    J Cell Sci; 2003 Oct; 116(Pt 19):3879-91. PubMed ID: 12953056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of junctional adhesion molecules on the human lymphatic endothelium.
    Ueki T; Iwasawa K; Ishikawa H; Sawa Y
    Microvasc Res; 2008 Mar; 75(2):269-78. PubMed ID: 17822725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions.
    Itoh M; Sasaki H; Furuse M; Ozaki H; Kita T; Tsukita S
    J Cell Biol; 2001 Aug; 154(3):491-7. PubMed ID: 11489913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relocalization of junctional adhesion molecule A during inflammatory stimulation of brain endothelial cells.
    Stamatovic SM; Sladojevic N; Keep RF; Andjelkovic AV
    Mol Cell Biol; 2012 Sep; 32(17):3414-27. PubMed ID: 22733993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling.
    Mandell KJ; Holley GP; Parkos CA; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2408-16. PubMed ID: 16723450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAM-A regulates epithelial proliferation through Akt/β-catenin signalling.
    Nava P; Capaldo CT; Koch S; Kolegraff K; Rankin CR; Farkas AE; Feasel ME; Li L; Addis C; Parkos CA; Nusrat A
    EMBO Rep; 2011 Apr; 12(4):314-20. PubMed ID: 21372850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Junctional Adhesion Molecule-A in Head and Neck Squamous Cell Carcinoma.
    Kurose M; Kakuki T; Takano K; Kondo A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Kojima T; Himi T
    Adv Otorhinolaryngol; 2016; 77():92-7. PubMed ID: 27115511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
    Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
    Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The JAM family of proteins.
    Mandell KJ; Parkos CA
    Adv Drug Deliv Rev; 2005 Apr; 57(6):857-67. PubMed ID: 15820556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology.
    Padden M; Leech S; Craig B; Kirk J; Brankin B; McQuaid S
    Acta Neuropathol; 2007 Feb; 113(2):177-86. PubMed ID: 17024496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Junctional adhesion molecule 1 (JAM-1).
    Naik UP; Eckfeld K
    J Biol Regul Homeost Agents; 2003; 17(4):341-7. PubMed ID: 15065765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.